You are here: Industry Insights > ulipristal acetate

News List

Ulipristal Acetate Introduction, Uses, Safety, and Where to Buy in Bulk PharmaSources.com
May 08, 2021
mechanism of action，pill specifications，uses , ect., of ulipristal acetate.
EMA safety committee recommends withdrawal of ulipristal acetate marketing authorisation europeanpharmaceuticalreview
September 18, 2020
The EMA’s PRAC has recommended the revocation of the marketing authorisation for ulipristal acetate, after a review confirmed liver injury caused by the medicine.
Allergan Receives Response Letter from FDA for Ulipristal Acetate americanpharmaceuticalreview
August 23, 2018
Allergan announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for ulipristal acetate (UPA) for the treatment of abnormal uterine bleeding in women with uterin
CAR-T therapies leap towards EU approval pharmatimes
July 04, 2018
The stage has been set for approval of the first chimeric antigen T-cell therapies (CAR-T) in Europe, after Novartis’ Kymriah and Gilead’s Yescarta both won backing from the Committee for Medicinal Products for Human Use (CHMP).